Medical News

RSS

BinaxNOW PBP2a test to detect PBP2a in MRSA

AdvanDx today announced that it will offer the BinaxNOW PBP2a test from Inverness Medical Innovations, Inc. (Waltham, MA) to customers in the United States. The test provides rapid detection of the penicillin-binding protein 2a present in Methicillin-Resistant Staphylococcus aureus (MRSA) directly from S. aureus positive blood cultures.

24 May 2010

Lawmakers could vote this week on three-year 'doc fix,' COBRA subsidy extension

Before they leave for the Memorial Day recess, lawmakers face legislation which includes a provision on Medicare payments to physicians and an extension of the COBRA subsidy to newly laid-off workers.

24 May 2010

66% of patients with schizophrenia have extreme trust in their psychiatrists: New survey

According to a new survey sponsored by Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, 80 percent of patients with schizophrenia, a chronic, severe and disabling brain disorder, say their psychiatrists do well or very well in treating them with courtesy and respect. This positive relationship is particularly important in treating schizophrenia as patients and psychiatrists must work closely together to determine appropriate treatment plans that will help patients manage their symptoms and reduce their risk of relapse.

24 May 2010

Thymosin beta 4 reduces brain tissue damage, improves brain function in rats: Research paper

RegeneRx Biopharmaceuticals, Inc. announced today that in a preclinical research paper published in the May 2010 issue of the Journal of Neurosurgery, (online ahead of publication), scientists found that the systemic administration of thymosin beta 4, or Tβ4, significantly reduced brain tissue damage and improved brain function in rats with traumatic brain injury, or TBI.

24 May 2010

OnePath Gaucher Application available for patients with Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today announced the availability of the OnePath Gaucher Application. The first and only application developed specifically for patients in the U.S. with Type 1 Gaucher disease, it is free and ready for download at the iTunes Application store.

24 May 2010

Study: Health law could mean penalties for one in three employers

News outlets covered analyses of health law provisions affecting businesses. "About one-third of employers subject to major requirements of the new health care law may face tax penalties because they offer health insurance that could be considered unaffordable to some employees, a new study says," The New York Times reports.

24 May 2010

Pro-Pharmaceuticals plans to submit Phase III trial design for DAVANAT to FDA

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced plans to submit a Phase III trial design for DAVANAT to the U.S. Food and Drug Administration during the second half of 2010. The Company has added the talent of Peter G. Traber, M.D., to its FDA approval strategy and trial design team.

24 May 2010

NormOxys raises $17.5M in Series B financing round

NormOxys, Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has raised $17.5 million in a Series B financing round. The financing was led by a new investor, Care Capital, LLC, with participation from existing venture investor Index Ventures.

24 May 2010

Zotec Partners announces strategic technology alliance with Florida-based MBS

Zotec Partners, an industry leader in medical billing, practice management and Radiology Information Systems software and services, is announcing today a strategic technology alliance with Florida-based Medical Business Service, Inc. This alliance enables Zotec Partners to further penetrate the radiology and pathology markets and strengthen its position as a leader in hospital-based revenue cycle management.

24 May 2010

Immunome announces completion of financing by BioAdvance

Immunome, a discovery-stage antibody platform company focused on life-threatening infectious diseases, announced today the completion of a financing by BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. The funding round also included private investors.

24 May 2010

Expression Analysis agrees to purchase PacBio RS DNA sequencing system from Pacific Biosciences

Expression Analysis, a leading provider of genomic services for clinical trials and research, announced today that it has agreed to purchase a PacBio RS DNA sequencing system from northern-California based Pacific Biosciences, whose third-generation DNA sequencing technology is expected to revolutionize the field of genetic analysis through the use of single molecule real time detection of biological events.

24 May 2010

Dole Nutrition Handbook recognized with prestigious Living Now Book Award

Dole Food Company, Inc. is pleased to have received the prestigious Living Now Book Award for the Dole Nutrition Handbook: What You Need to Eat And How To Live For A Longer Healthier Life. The gold medal award is the top honor in the competition's Nutrition & Diet category. On Earth Day each year, the Jenkins Group - an organization dedicated to promoting books that enrich readers' lives in Earth friendly ways - presents the Living Now Book Awards to honor "books for better living."

24 May 2010

China Yongxin Pharmaceuticals first-quarter 2010 revenues increase 16.3% to $10.68M

China Yongxin Pharmaceuticals Inc., one of the leading health products distribution and retail sales companies in China, today announced its financial results for the first quarter ending March 31, 2010.

24 May 2010

BHS selects Compuware's EHR Service Delivery Solution to monitor performance of its EHR systems

Compuware Corporation today announced that Baptist Health System, one of the largest not-for-profit healthcare systems and employers in Alabama, has selected Compuware's EHR Service Delivery Solution—powered by Compuware Vantage—to monitor the performance and availability of its Electronic Health Record systems and ensure Service Level Agreements are being met.

24 May 2010

New FDA approved Landon Medical LM-800 Finger Pulse Oximeter available for home use

PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new, affordable $39 FDA approved Landon Medical LM-800 Finger Pulse Oximeter for home use.

24 May 2010

ZyGEM announces acquisition of MicroLab Diagnostics

ZyGEM Corp. Ltd., today announced that it has acquired MicroLab Diagnostics Inc., a private company developing microfluidic devices for rapid DNA testing. ZyGEM intends to market products integrating its unique DNA extraction and reagents and detection assays with the breakthrough microfluidic chip technology developed by MicroLab, which will operate as a business unit of the new company.

24 May 2010

Salix Pharmaceuticals announces availability of Xifaxan tablets for reducing risk of overt HE recurrence

Salix Pharmaceuticals, Ltd. today announced the availability of Xifaxan (rifaximin) 550 mg tablets for the reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. Those HE patients may now fill their Xifaxan 550 mg prescriptions in U.S. pharmacies and should speak with their doctors about this important treatment option.

24 May 2010

Toshiba launches new Web site for patients receiving diagnostic imaging exams

To help patients work with their physicians to better understand medical imaging, Toshiba America Medical Systems, Inc. has launched myimagingexam.com, an educational resource Web site for patients receiving diagnostic imaging exams. The new site provides educational tools for patients to download and use with their physician before undergoing a medical imaging exam to better understand the imaging process and manage their own health.

24 May 2010

Enrollment in phase II clinical trial of brentuximab vedotin for ALCL completed

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that they have completed enrollment of a phase II clinical trial of brentuximab vedotin (SGN-35) for relapsed or refractory systemic anaplastic large cell lymphoma.

24 May 2010

Sangamo's ZFP Therapeutics technology highlighted at ASGCT Annual Meeting

Sangamo BioSciences, Inc. announced today that data from research and preclinical programs focused on the development of zinc finger DNA-binding protein Therapeutics were described in fifteen presentations given by Sangamo scientists and collaborators at the 13th Annual Meeting of the American Society of Gene and Cell Therapy.

24 May 2010